News Daily News REMEDEE Published: ‘Dual Therapy’ Stent Passes Early Efficacy, Safety Tests April 05, 2013
News Daily News Pair of Studies Support Paclitaxel-Eluting Devices for Treating Femoropopliteal Disease Caitlin E. Cox April 05, 2013
News Industry News ARTHESYS receives CE mark for its 4th generation MAYA PTCA catheter March 28, 2013
News Daily News Study Looks at Adding Corticosteroid Treatment to Bare-Metal Stenting Jason Kahn March 25, 2013
News Daily News BIOSOLVE-1 Shows Improvement in Paclitaxel-Eluting Bioabsorbable Stent March 25, 2013
News Industry News With Medtronic Resolute Stent, Interrupting Dual Antiplatelet Therapy After One Month Showed No Increased Safety Risk in Robust Analysis March 11, 2013
News Industry News New Data Reinforce Strong Long-Term Clinical Performance of Abbott's Absorb™ Bioresorbable Vascular Scaffold March 11, 2013
News Conference News ACC 2013 Aspirin Alone Just as Good as Dual Antiplatelet Therapy Beyond 12 Months Jason Kahn March 11, 2013
News Conference News ACC 2013 Is Nobori NEXT? Biodegradable-Polymer DES Noninferior to EES Jason Kahn March 09, 2013
News Industry News Medtronic Approved to Update Resolute Integrity Stent’s ‘CE’ Mark Labeling on Dual Antiplatelet Therapy March 03, 2013
News Industry News FDA Approves Longer Lengths of Medtronic’s Resolute Integrity Stent February 24, 2013
News Daily News Infrapopliteal Angioplasty Shows Long-term Promise for Critical Limb Ischemia Yael L. Maxwell February 14, 2013
News Industry News Promus PREMIER™ Everolimus-Eluting Platinum Chromium Stent System Receives CE Mark Approval February 11, 2013
News Daily News ISAR-DESIRE 3 Published: Paclitaxel-Eluting Balloons Match PES for DES Restenosis Caitlin E. Cox February 07, 2013
News Daily News Self-Expanding Nitinol Stent Potential Option in Popliteal Artery Disease January 24, 2013
News Daily News Ideal Duration of Dual Antiplatelet Therapy May Depend on Stent Type Jason Kahn January 22, 2013
News Daily News Novel Anti-inflammatory May Reduce Restenosis After BMS in High-Risk Patients L.A. McKeown January 13, 2013
News Daily News CABG More Cost-Effective in Patients with Diabetes, Multivessel Disease Over Long Term Yael L. Maxwell January 09, 2013